TW264472B - - Google Patents

Info

Publication number
TW264472B
TW264472B TW082101559A TW82101559A TW264472B TW 264472 B TW264472 B TW 264472B TW 082101559 A TW082101559 A TW 082101559A TW 82101559 A TW82101559 A TW 82101559A TW 264472 B TW264472 B TW 264472B
Authority
TW
Taiwan
Prior art keywords
amino
2alkyl
cyclosporins
alkylthio
pharmaceuticals
Prior art date
Application number
TW082101559A
Other languages
English (en)
Original Assignee
Samdoz Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samdoz Pharmaceutical Factory filed Critical Samdoz Pharmaceutical Factory
Application granted granted Critical
Publication of TW264472B publication Critical patent/TW264472B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW082101559A 1992-03-02 1993-03-03 TW264472B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204466A GB9204466D0 (en) 1992-03-02 1992-03-02 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
TW264472B true TW264472B (zh) 1995-12-01

Family

ID=10711333

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082101559A TW264472B (zh) 1992-03-02 1993-03-03

Country Status (26)

Country Link
US (1) US5643870A (zh)
EP (1) EP0577544B1 (zh)
JP (1) JP3382656B2 (zh)
KR (1) KR100256988B1 (zh)
CN (1) CN1037104C (zh)
AT (1) ATE146484T1 (zh)
AU (1) AU667072B2 (zh)
CA (1) CA2090634C (zh)
CZ (1) CZ285421B6 (zh)
DE (1) DE69306670T2 (zh)
DK (1) DK0577544T3 (zh)
ES (1) ES2096262T3 (zh)
FI (1) FI111729B (zh)
GB (1) GB9204466D0 (zh)
GR (1) GR3022539T3 (zh)
HU (1) HU214028B (zh)
IL (1) IL104891A (zh)
MX (1) MX9301129A (zh)
MY (1) MY106921A (zh)
NO (1) NO310685B1 (zh)
NZ (1) NZ247031A (zh)
PL (1) PL174816B1 (zh)
RU (1) RU2131883C1 (zh)
SK (1) SK279529B6 (zh)
TW (1) TW264472B (zh)
ZA (1) ZA931491B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639852A (en) * 1994-09-01 1997-06-17 Wisconsin Alumni Research Foundation Immunostimulatory agents
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
US20030087813A1 (en) * 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
ES2266564T3 (es) * 2001-10-19 2007-03-01 Isotechnika Inc. Sintesis de analogos de cicloporinas.
US7012065B2 (en) * 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
JP2008514701A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
JP2008515886A (ja) * 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
JP4735861B2 (ja) * 2004-11-22 2011-07-27 アステラス製薬株式会社 新規環状ペプチド化合物
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
CA3014633C (en) 2007-10-08 2022-05-17 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
CN102164948A (zh) * 2008-07-30 2011-08-24 伊索技术制药公司 非免疫抑制的环孢菌素类似分子
JP2012529509A (ja) 2009-06-09 2012-11-22 ラックス・バイオサイエンシーズ・インコーポレイテッド 眼科用用途のための局所薬物送達システム
US20130267460A1 (en) * 2010-09-16 2013-10-10 The Johns Hopkins University Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
WO2012079172A1 (en) 2010-12-15 2012-06-21 Isotechnika Pharma Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
CN105076117B (zh) * 2014-10-31 2017-08-25 北京林业大学 一种种子抗老化剂及其制备方法
KR20170000243U (ko) 2015-07-09 2017-01-18 (주)하나피앤씨 배관연결용 플랜지 기구
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
CA2004626A1 (en) * 1988-12-05 1990-06-05 Bernard F. Erlanger Derivatives of cyclosporine a, antibodies directed thereto and uses thereof
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
DE69124459T3 (de) * 1990-11-02 2001-05-31 Novartis Ag, Basel Zyklosporine

Also Published As

Publication number Publication date
CZ30393A3 (en) 1994-02-16
NZ247031A (en) 1995-05-26
JP3382656B2 (ja) 2003-03-04
IL104891A0 (en) 1993-07-08
GR3022539T3 (en) 1997-05-31
ES2096262T3 (es) 1997-03-01
HU214028B (en) 1997-12-29
NO930738D0 (no) 1993-03-01
EP0577544A1 (en) 1994-01-05
HUT64567A (en) 1994-01-28
HU9300418D0 (en) 1993-05-28
FI930912A0 (fi) 1993-03-01
DK0577544T3 (da) 1997-04-01
KR100256988B1 (ko) 2000-05-15
NO310685B1 (no) 2001-08-13
CA2090634A1 (en) 1993-09-03
JPH07252296A (ja) 1995-10-03
US5643870A (en) 1997-07-01
CN1076453A (zh) 1993-09-22
CN1037104C (zh) 1998-01-21
ATE146484T1 (de) 1997-01-15
CZ285421B6 (cs) 1999-08-11
RU2131883C1 (ru) 1999-06-20
SK279529B6 (sk) 1998-12-02
CA2090634C (en) 2005-12-13
MX9301129A (es) 1994-07-29
ZA931491B (en) 1994-09-02
SK14093A3 (en) 1993-10-06
AU667072B2 (en) 1996-03-07
IL104891A (en) 1997-04-15
EP0577544B1 (en) 1996-12-18
DE69306670D1 (de) 1997-01-30
KR930019692A (ko) 1993-10-18
GB9204466D0 (en) 1992-04-15
PL174816B1 (pl) 1998-09-30
AU3387293A (en) 1993-09-09
MY106921A (en) 1995-08-30
PL297902A1 (en) 1993-09-06
DE69306670T2 (de) 1997-07-03
NO930738L (no) 1993-09-03
FI111729B (fi) 2003-09-15
FI930912A (fi) 1993-09-03

Similar Documents

Publication Publication Date Title
TW264472B (zh)
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
MY109143A (en) Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
ZA937112B (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstaniene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions contning same
EP0556912A3 (en) Rapid plasma hydrogenation process for polysilicon mosfet's
GB9305718D0 (en) Medicaments
ZA912075B (en) Novel retinoids
HK1012847A1 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
MX9505078A (es) Procedimientos para la preparacion de halogenodifluoroacetatos de alquilo.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
ZA942686B (en) Active compound from a sponge
BG101325A (en) Use of muramyl peptide compounds
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
MY111222A (en) N-[[1-[4-(4-fluorophenoxy)butyl]-4-piperidinyl]-n-methyl-amino]-2-benzothiazolols as class iii antiarrhythmic agents.
IT1256925B (it) Impiego di frammenti o/e di derivati della timosina alfa 1.
IT226014Y1 (it) Dispositivo per l'erogazione di ossigeno terapeutico portatile per l'e mergenza e utilizzabile anche come aerosol con innesto di fiala con es
BG101119A (en) Analgesic composition
AU116248S (en) Cover
ITTE930001A1 (it) Procedimento per l'arricchimento del tenore in zeoliti di sottoprodotti delle cave di blocchetti di "tufo litoide"
AU119820S (en) Resuscitator recoil bag